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This study was carried out to evaluate the effects of noscapine, a benzylisoquinoline alkaloid from opium poppy, on 
oligodendrocyte during ischemia/reperfusion-induced excitotoxic injury. Changes in intracellular calcium levels due 
to chemical ischemia and nitric oxide (NO) production during ischemia/reperfusion were evaluated as the hallmarks 
of ischemia-derived excitotoxic event. OLN-93 cell line (a permanent immature rat oligodendrocyte) was used as a 
model of oligodendrocyte. 30- or 60-minute-oxygen–glucose deprivation/24 hours reperfusion were used to induce 
excitotoxicity. MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) assay was used to evaluate 
cell viability. Ratiometric fluorescence microscopy using Ca2+-sensitive indicator Fura-2/AM was utilized to assess 
intracellular calcium levels. NO production was evaluated by Griess method. Noscapine (4 μM) significantly 
attenuated intracellular Ca2+ elevation (P < 0.001). Also, noscapine significantly decreased NO production during a 
30-minute oxygen–glucose deprivation/reperfusion (P < 0.01). The inhibitory effect of noscapine (4 μM) on 
intracellular Ca2+ was greater than ionotropic glutamate receptors antagonists. Noscapine is protective against 
ischemia/reperfusion-induced excitotoxic injury in OLN-93 oligodendrocyte. This protective effect seems to be 
related to attenuation of intracellular Ca2+ overload and NO production. 
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Noscapine is a benzylisoquinoline alkaloid derived from opium poppy (Papaver somniferum) 
(5, 61). Noscapine, with very few side effects and no addiction liability, has been used as 
an antitussive drug for many years (30, 48). Recently, it has been demonstrated that 
noscapine is a tubulin-binding, anti-angiogenic anticancer drug, which effectively inhibits 
the progression of various cancer types both in vitro and in vivo with no evident side effects 
(30, 48). Furthermore, noscapine induces apoptosis dose-dependently in high concentrations 
(12). The important effects of noscapine on reducing the extent of ischemic brain injury in an 
animal model and mortality rate in stroke patients were demonstrated by Mahmoudian et al. 
in two separate studies (31, 32). 
Oligodendrocytes, the myelinating cells, are particularly vulnerable to ischemic shock 
and glutamate excitotoxic damage (10, 36), associated with acute and chronic diseases 
affecting white matter such as stroke and multiple sclerosis (MS) (10, 56). 
Excitotoxicity is a phenomenon whereby overactivation of ionotropic glutamate 
receptors (GluRs) provokes cell death and the intracellular Ca2+ overload appears to be the 
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main part of this lethal event (36, 38). Among three types of ionotropic glutamate receptors, 
N-methyl-D-aspartate (NMDA) receptors have the major role in neuronal excitotoxicity 
although α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and kainate 
(KA) receptors have been implicated as well (18, 36). In oligodendrocytes, the major cell 
type of white matter, which are extremely vulnerable to excitotoxic and ischemic insult, 
NMDA receptors are expressed in clusters on oligodendroglial processes while AMPA and 
kainate receptors are distributed on oligodendrocyte somata (10, 34). Particularly, immature 
oligodendrocytes are found to be even more sensitive to ischemic injury than their more 
mature correlates (37). 
NMDA receptors are the main route of Ca2+ influx, but changes in molecular 
characteristics of AMPA/kainate receptors in oligodendrocytes, may cause additional 
permeability to Ca2+, and enhance sensitivity of oligodendrocytes to excitotoxic insult (34, 
36). For example, lack of the GluR2 subunit of AMPA receptors in differentiated 
oligodendrocytes and expression of the edited GluR6 subunit in low extent in oligodendroglial 
cells make these receptors more permeable to Ca2+ (36). 
Nitric oxide (NO) mediates various normal physiologic functions as a messenger 
molecule (20). Different isoforms of nitric oxide synthase (NOS) produce NO. For instance, 
neuronal NOS (nNOS) is present exclusively in neurons and the inducible NOS (iNOS) can 
be activated in glial cells; iNOS and nNOS are present in oligodendrocytes (59, 60). Other 
than the physiological actions, NO can cause cellular damage and act as a key mediator of 
neurodegeneration in many diseases, including Parkinson’s disease, Alzheimer’s disease, 
amyotrophic lateral sclerosis, Huntington’s disease, and stroke (20). Moreover, there is the 
evidence for association of nNOS activation with the loss of oligodendrocytes and 
demyelination (59, 60). 
OLN-93 cell line is used as a model of oligodendrocytes for in vitro studies; the OLN-93 
cells based on their morphological and antigenic characteristics are comparable to 5- to 
10-day-old (postnatal time) cultured rat brain oligodendrocytes, so this cell line is identified 
as immature oligodendrocyte (4, 43, 58). 
This study was designed to verify if noscapine could protect OLN-93 oligodendrocytes 
against oxygen–glucose deprivation/reperfusion-induced excitotoxicity. Besides, intracellular 
calcium levels during chemical ischemia, and NO production after ischemia/reperfusion 
were evaluated as important factors involved in ischemia-induced excitotoxic event. 
Materials and Methods
Materials 
Noscapine was obtained from Sigma Chemical Co. (St. Louis, MO, USA). The stock solution 
was prepared at 1 mmol/l in dimethylsulfoxide (DMSO) and kept at –20 °C. Dulbecco’s 
Modified Eagle’s medium (DMEM) with glutamine, glucose/glutamine-free DMEM, 
fetal bovine serum (FBS) were purchased from GIBCO. Penicillin-streptomycin, 
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT), poly-L-lysine, 
Dizocilpine (MK-801), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione 
(NBQX), NG nitro-L-arginine methyl ester (L-NAME), modified Griess reagent, and Fura 
2-AM were purchased from Sigma Chemical Co. (St. Louis, MO, USA). All other chemicals 
are of the purest grade available from regular commercial sources.
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Cell culture
OLN-93 cell line was purchased from Pasteur Institute of Iran (Tehran, Iran). The cells were 
grown in DMEM medium supplemented with 10% FBS and 100 IU/ml penicillin and 100 
µg/ml streptomycin in a humidified 95% air and 5% CO2 incubator at 37 °C. The cells were 
sub-cultured twice a week by gentle scraping and were cultured on poly-L-lysine-coated 
12-well plates at a density of 5×104. Culture dishes were coated with poly-L-lysine 24 hours 
before the experiment. Poly-L-lysine (150 000–300 000 MW) was dissolved in deionized 
water and the plate wells were filled with this solution (20 µg/ml). After 5 minutes standing 
at room temperature, the solution was aspirated and the plates were left to dry in a laminar 
flow hood overnight. Cells were used for experiments 24 hours after seeding. 
Oxygen–glucose deprivation and drug exposure 
Ischemia/ reperfusion is a well established model in in vitro, in vivo and ex vivo pharmacological 
studies to evaluate the effects of drugs in different cell types such as neural, renal and cardiac 
cells or organs (14, 19, 25, 26, 47, 52, 53, 55). For instance, brief or lethal episodes of 
ischemia/reperfusion are useful methods in cardioprotection studies (11).
Procedures for oxygen–glucose deprivation (OGD) were performed as described 
previously (9). Briefly, the culture medium was replaced with glucose/glutamine-free 
DMEM, and cells were exposed to hypoxia for 30 and 60 minutes in a small anaerobic 
chamber filled with 95% (v/v) N2 and 5% (v/v) CO2 at 37 °C. To terminate the oxygen–
glucose deprivation, the chamber was opened and the medium was replaced with DMEM, 
and the cultures were then placed in an incubator with 5% CO2 for 24 hours. To examine the 
drug effects, cell cultures were treated 3 hours before oxygen–glucose deprivation with 
noscapine, at concentrations of 1–5 µM. The pre-incubation time of 3 hours was selected 
based upon previous studies (42). These concentrations were chosen based on the results of 
preliminary experiments at nontoxic levels of noscapine (data not shown). To investigate the 
effects of various inhibitors on oxygen–glucose deprivation-induced cell death, MK-801, a 
non-competitive antagonist of the NMDA receptor or NBQX, an AMPA/kainate receptor 
antagonist, was added to the medium 3 hours before oxygen–glucose deprivation (52). Plates 
not exposed to oxygen–glucose deprivation were used as external control and those exposed 
to oxygen–glucose deprivation conditions without the addition of any drug were used as 
internal control. All measurements were duplicated and each experiment was repeated at 
least three times. Every data point is therefore the mean of at least six measurements.
Analysis of cell viability
Oligodendroglial cell viability was measured using the colorimetric MTT assay, as previously 
described by Mosmann (40). Briefly, cells were incubated with 0.5 mg/ml MTT in DMEM, 
at 37 °C under 5% CO2, for 3 hours. The blue formazan reduction product, produced by the 
action of succinate dehydrogenase in living cells on the dye, was dissolved in 100 µl DMSO, 
and the optical density was read at 570 nm using a Dynex MRX microplate reader (Dynex, 
Richfield, MN, USA). Data were expressed as the percentage of viable cells in oxygen–
glucose deprivation-exposed plates compared with control normoxic plates determined by 
MTT reduction.
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Measurement of intracellular free calcium 
Measurement of intracellular free calcium concentration was performed using a Ca2+-
sensitive indicator Fura 2-AM on an Olympus IX-71 inverted microscope and CCD camera. 
Fluorescence emission images of intracellular Fura-2 at 510 nm, after excitation at two 
different wavelengths, i.e. 340 and 380 nm, were acquired (54). Ratiometric analysis of 
image pairs was carried out using Image J (National Institute of Health (NIH), Bethesda, 
Maryland, USA), and Excel (Microsoft; Seattle, WA, USA) softwares (44). Sodium azide 
(NaN3), a specific inhibitor of complex IV, is well accepted to induce chemical hypoxia in 
vitro and in vivo (28, 62). Moreover, the chemical hypoxia induced by mitochondrial toxins 
produces a secondary excitotoxicity, leading to the activation of NMDA receptors. Therefore, 
sodium azide, as an inhibitor of cytochrome oxidase, induces the release of excitotoxins via 
energy impairment, so this results in neurodegeneration (21). Also, the analysis of cell 
viability by MTT assay demonstrated that sodium azide by inducing mitochondrial 
dysfunction could provide a common platform for investigating the mechanisms of both 
ischemic and degenerative neuronal damage, useful for testing potential protective agents 
against neuronal death (46).
OLN-93 oligodendrocytes were pre-incubated for 30 minutes with Fura-2 AM (5 μM) 
at room temperature. Incubation was continued for a further 15 minutes at 37 oC (44). Cells 
were placed in a flow-chamber and washed with isotonic buffer containing (in mM): 128 
NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 10 glucose and 10 HEPES, pH 7.4 for 10 minutes (1, 16). 
The flow rate was 0.5 ml/min and the temperature was kept at 37 oC. Chemical oxygen-
glucose deprivation was started by flow of sodium azide (NaN3: 20 mM) in glucose free 
isotonic buffer for 30 minutes (33, 57, 62). The concentration of sodium azide (20 mM) was 
selected based on the study by Marino et al. (33). Our experiments showed that this 
concentration produced a significant elevation of intracellular calcium in OLN-93 cells 
through 30 minute-chemical oxygen–glucose deprivation. Images were taken for 4-minute-
durations along with 10-minute pauses at start, middle and the end of 30 minutes chemical 
oxygen–glucose deprivation. Noscapine and other drugs were dissolved in sodium azide (20 
mM) to evaluate the alteration of intracellular calcium levels in the presence and absence of 
drugs during 30 minutes of chemical oxygen–glucose deprivation. 
Measurement of nitrite
The level of nitrite as a measure of NO production in the culture medium was quantified 
using modified Griess reagent. In brief, the medium in each well was removed and centrifuged 
at 10 000 × rpm for 10 minutes at 4 °C. Then, the supernatant was mixed with an equal 
volume of modified Griess reagent at room temperature for 10 minutes, and the absorbance 
was measured at 540 nm using an Ultrospec® 3000 UV/Visible spectrophotometer (Pharmacia 
Biotech, Cambridge, England). The nitrite concentration was determined from a sodium 
nitrite standard curve. Plates not exposed to oxygen–glucose deprivation were used as 
external control and those exposed to oxygen–glucose deprivation conditions without the 
addition of any drug were used as internal control.
Statistical analysis
All results are expressed as mean ± SD. The significance of differences was evaluated using 
Student’s t-test by Excel 2007 (Microsoft; Seattle, WA, USA) software. For multiple 
comparisons we used One Way ANOVA (Tukey’s post hoc) using SPSS 16 (International 
Business Machines Corporation, 1 New Orchard Road Armonk, New York 10504-1722, 
USA). P value of < 0.05 was considered statistically significant. 
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Results
The effects of noscapine, on oxygen–glucose deprivation/reperfusion-induced cell injury  
in OLN-93 cells 
MTT assay demonstrated that cell viability decreased to 52% and 40% during 30 (Fig. 1A) 
and 60 minutes (Fig. 1B) oxygen-glucose deprivation/reperfusion, respectively. Pretreatment 
of cultures with noscapine (1–5 μM), significantly attenuated oxygen-glucose deprivation-
induced cell injury in OLN-93 cells in a concentration-dependent manner (P < 0.001). The 
peak of protective effect was at 4 μM for noscapine through the time-scheduled experiments. 
At this concentration, noscapine increased cell viability to 79% and 69%, during 30 and 60 
minutes of oxygen-glucose deprivation/reperfusion, respectively (P < 0.001).
Fig. 1. The effects of noscapine (1–5 μM), MK-801 (10 μM), NBQX (30 μM), and L-NAME (100 μM) on 
oxygen–glucose deprivation/24 hours reperfusion-induced cell injury in cultured OLN-93 oligodendrocytes. 
Optical density (OD) at 570 nm corresponds to the blue formazan reduction product which is produced by the 
action of mitochondrial succinate dehydrogenase in living cells and correlates to cell viability. The control 
normoxic plates were considered as 100% viability and those exposed to oxygen–glucose deprivation conditions 
without the addition of any drug were used as internal control. Data are expressed as mean percentage of viable 
cells (SD) in oxygen–glucose deprivation-exposed plates compared with internal control (*** P < 0.001).  
(A) Cell viability after 30 minutes of oxygen–glucose deprivation/24 hours reperfusion.  
(B) Cell viability after 60 minutes of oxygen–glucose deprivation/24 hours reperfusion
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The effects of MK-801, NBQX and L-NAME on oxygen–glucose deprivation/reperfusion-
induced cell injury in OLN-93 cells
To evaluate the effects of inhibitors of ionotropic glutamate receptors on ischemia/reperfusion-
induced cell death, cells were treated with MK-801 (10 μM) and NBQX (30 μM) 3 hours 
before oxygen–glucose deprivation. Our results revealed that MK-801 and NBQX could 
significantly protect the OLN-93 cells from oxygen–glucose deprivation-induced cell death 
during both time-scheduled assessments in comparison with internal control (P < 0.001). 
MK-801 increased cell viability to 69% and 63% during 30 and 60 minutes of oxygen-
glucose deprivation/reperfusion, respectively. Moreover, NBQX improved cell viability to 
67% and 65% during same time-scheduled assessments, respectively. Furthermore, L-NAME 
(100 μM), a NOS inhibitor, increased cell viability to 76% after 30 minutes of oxygen-
glucose deprivation/reperfusion (Fig. 1A, B).
The effects of noscapine, MK-801 and NBQX on intracellular calcium levels during  
a 30-minute chemical oxygen-glucose deprivation in OLN-93 cells 
To determine the intracellular calcium levels during ischemia, the OLN-93 cells were exposed 
to sodium azide (NaN3: 20 mM), as a model of chemical oxygen-glucose deprivation, for 30 
minutes. Sodium azide was able to induce 135% increase in intracellular Ca2+ concentration 
which was statistically significant compared with baseline. Furthermore, the ischemia-
evoked increase in intracellular Ca2+ levels was decreased to 117% by noscapine (4 µM), 
121% by MK-801 (10 µM) and 127% in the presence of NBQX (30 µM) compared to pre-
oxygen-glucose deprivation levels. Reduction in intracellular Ca2+ levels in the presence of 
noscapine or ionotropic glutamate receptors inhibitors was significant in comparison with 
chemical oxygen-glucose deprivation in absence of these drugs (P < 0.001) (Fig. 2).
Fig. 2. Assessment of intracellular Ca2+ during 30-minute chemical oxygen-glucose deprivation (OGD)  
in OLN-93 oligodendrocytes. Typical results based on Fura 2-AM fluorescence ratio (F340 nm/F380 nm)  
to evaluate the intracellular Ca2+ levels during 30-minute chemical OGD by sodium azide (NaN3: 20 mM).  
All the procedures were performed in Ca2+-containing incubation buffer. The cells were incubated with  
Fura 2-AM. The images were taken in 4-minute durations fallowed by 10 minute-pauses during chemical  
OGD to evaluate the alteration of intracellular Ca2+ levels. The basic level of intracellular Ca2+ during buffer  
wash was considered 100%. Sodium azide induced an increase in intracellular Ca2+ levels, an effect that was 
reduced by noscapine (4 μM), MK-801 (10 μM) and NBQX (30 μM) (P < 0.001)
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The effects of noscapine, L-NAME and MK-801 on nitric oxide production during 
30-minute oxygen-glucose deprivation/reperfusion in OLN-93 cells
NO production in the culture medium was measured by modified Griess reagent after 30 
minutes oxygen-glucose deprivation/reperfusion. Exposure of OLN-93 cells to 30 minutes of 
oxygen–glucose deprivation/reperfusion significantly increased nitrite production compared 
with the external control (P < 0.001). Pretreatment of cultures with noscapine (4 µM), 
significantly decreased NO production, as compared with the oxygen-glucose deprivation 
control (P < 0.01). The effects of L-NAME (100 μM), a NOS inhibitor, and MK-801 (10 
μM), a non-competitive antagonist of the NMDA receptor, on NO production were also 
evaluated, and both compounds reduced the NO production, significantly (P < 0.001; P < 
0.01, respectively) (Fig. 3). 
Fig. 3. The effects of noscapine (4 μM), L-NAME (100 μM), and MK-801 (10 μM) on nitric oxide (NO) 
production during a 30-minute oxygen–glucose deprivation (OGD)/24 hours reperfusion-induced cell injury in 
cultured OLN-93 oligodendrocytes. The plates not exposed to oxygen–glucose deprivation were used as external 
control and those exposed to oxygen–glucose deprivation conditions without the addition of any drug were used as 
OGD control. The values are presented as mean (SD) compared with OGD control.  
(** P < 0.01; *** P < 0.001)
Discussion
Noscapine, a nontoxic natural compound, was most known for its antitussive effect (27, 61). 
Various studies reported dual effects for noscapine. For the first time, Joshi et al. showed it 
had potent anti-tumor activity for which it is already in Phase I/II clinical trials (27, 61). In 
this regard, noscapine induced cytotoxic effects on myeloid leukemia cells that were treated 
for 72 hours in the presence of different high concentrations of noscapine (i.e. > 5 μM) and 
is capable to induce apoptosis (12). However, noscapine has several protective effects in 
non-toxic concentrations. Noscapine as an antitussive compound in low concentrations (i.e. 
< 1 μM) presented a specific antagonistic effect on bradykinin receptors through bradykinin-
induced smooth muscle contraction in the isolated ileum of the guinea-pig (29). Mahmoudian 
et al. presented the usefulness of noscapine in decreasing the extent of brain injury after 
hypoxic-ischemic damage in neonatal rats (32). Moreover, through a clinical trial, they show 
that the oral administration of noscapine to the acute ischemic stroke patients effectively 
improved clinical prognosis and reduced mortality without any specific side effects (31). 
358
Acta Physiologica Hungarica 102, 2015
Nadjafi S et al.
Also, Hiser et al. revealed that noscapine could protect against vincristine-derived 
demyelination in cell cultures containing neurons, astrocytes, and oligodendrocytes (13). 
In this study, we evaluated the effect of noscapine on OLN-93 oligodendrocytes during 
30 or 60 minutes oxygen-glucose deprivation followed by 24 hours reperfusion. The alteration 
of intracellular calcium levels during a 30-minute chemical ischemia, and nitric oxide 
production after 30 minutes oxygen-glucose deprivation/reperfusion were assessed. 
Oligodendroglial damage due to excitotoxicity is a main point in demyelinating diseases 
such as multiple sclerosis, and an important factor in ischemic injuries such as stroke (34, 38, 
45). It has been known that immature and differentiated oligodendrocytes in vitro are the 
most susceptible cells of the white matter to transient oxygen and glucose deprivation (35). 
Notably, during simulated ischemia, NMDA and AMPA/kainate receptors, based on their 
locations, both take part in producing Ca2+-dependent injury in processes and somata of 
oligodendroglial cells (45). All in all, calcium ions are the mediator of excitotoxicity in 
oligodendrocytes (7, 35, 45). 
The results of MTT assay revealed that, noscapine could significantly protect the OLN-
93 cells from ischemia/reperfusion-induced injury in a concentration dependent manner 
through time-scheduled assessments. Our results are in accord with the findings of previous 
studies, which pointed to the effectiveness of noscapine on hypoxic-ischemic insults (31, 32). 
Moreover, MK-801 and NBQX, antagonists of ionotropic glutamate receptors, significantly 
protected the OLN-93 oligodendrocytes against oxygen-glucose deprivation/reperfusion-
induced damage. Formerly, it was believed that oligodendrocytes lack the NMDA-ionotropic 
glutamate receptors, and they merely present the AMPA/kainate receptors, but there is 
increasing evidence of the presence of NMDA receptors as well (6, 23, 37, 41). In late 2005, 
it was clarified that, AMPA and kainate receptors are expressed on the cell body of the 
oligodendrocytes, and NMDA receptors are found on the distal processes of the 
oligodendroglial cells and myelin (15, 45). Salter and Fern explained that the blockade of 
AMPA/kainate and NMDA receptors could protect oligodendroglial cells against Ca2+-
dependent injury through oxygen glucose deprivation (45). The results of this study are in 
accord with the Salter and Fern’s findings and confirmed the protective effect of ionotropic 
glutamate receptors antagonists against ischemia-induced injury in oligodendrocytes. 
Furthermore, our results indicated that MK-801 was more effective than NBQX on cell 
protection during 30 minutes of oxygen–glucose deprivation/reperfusion. In a 60-minute 
oxygen–glucose deprivation, application of the same concentrations of MK-801 and NBQX 
resulted in a more protective effect of NBQX than that of MK-801. This is consistent with 
previous findings on cortical neurons, that indicated that AMPA-kainate receptors modulate 
a more slowly-triggered excitatoxic injury than NMDA receptors do (8, 22, 52). Interestingly, 
noscapine at 4 µM had greater protective effect than ionotropic glutamate receptors 
antagonists in both the 30- and 60-minute-scheduled oxygen–glucose deprivation/reperfusion 
experiments. This indicates that other mechanisms may be involved in protective effects of 
noscapine.
Next, we intended to know if the protective effect of noscapine was associated with 
alteration in intracellular Ca2+ overload and NO production. Therefore, we selected the 
30-minute courses of chemical ischemia and oxygen–glucose deprivation/reperfusion to 
determine the intracellular Ca2+ levels and NO production. 
In this study, chemical oxygen-glucose deprivation by sodium azide and Ca2+-sensitive 
indicator Fura-2/AM were used to assess intracellular calcium levels.
Sodium azide (NaN3), a well-accepted specific inhibitor of complex IV, has been used to 
induce chemical hypoxia both in vitro and in vivo (28, 62). In vitro model of brain ischemia 
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by sodium azide increased intracellular Ca2+ in neurons (33). It has been demonstrated that, 
in this model the dominant source of calcium elevation is extracellular, comprising glutamate 
receptor activation in a first phase and calcium channel opening in a second phase (33). Thus, 
we applied sodium azide in glucose free isotonic buffer to assess the intracellular Ca2+ 
overload in OLN-93 oligodendrocytes. 
The results showed that the significant rise in intracellular Ca2+ levels due to 30 minute-
sodium azide challenge was attenuated significantly by noscapine. Also, MK-801 and NBQX 
significantly decreased the intracellular calcium levels in this condition. Interestingly, the 
effects of noscapine on intracellular Ca2+ levels were significantly greater compared with 
ionotropic glutamate receptors antagonists. The findings of MTT assay from the 30-minute-
oxygen-glucose deprivation/reperfusion experiment were confirmed by the results of 
intracellular Ca2+ levels assessment; thus, reduction of the intracellular Ca2+ overload by 
noscapine seems to be important in protecting of ONL-93 cells during ischemia-induced 
excitotoxic injury. 
Nitric oxide has an important function in excitotoxic pathways mediated by NMDA Ca2+ 
channels (20). In neurons, nNOS is partly bound close to the NMDA receptor, and is activated 
by calcium entry via the receptor-gated ion channel (2). In vitro studies demonstrated that 
NMDA-induced neurotoxicity was decreased by NOS inhibitors, was also dampened in 
neurons isolated from nNOS–/– mice (2). In addition, in vivo damage induced by a model of 
brain ischemia was reduced by treatment with NOS inhibitors in nNOS–/– mice (2). This 
evidence suggests that nNOS activation, because of NMDA receptor activation, might 
contribute to neuronal excitotoxic death (2). 
There are few studies about the role of nitric oxide during excitotoxicity in 
oligodendrocytes. Markedly, Kaur et al. indicated that excitotoxicity and nitric oxide are 
involved in periventricular white matter (corpus callosum) damage in response to hypoxia 
(17). Their investigations on neonatal brain of Wistar rats demonstrated that the up-regulation 
of mRNA and protein expression of three kinds of nitric oxide synthase: eNOS, nNOS and 
iNOS could be detected in corpus callosum in response to hypoxia (17). In addition, NO 
levels were significantly elevated in hypoxic rats up to 14 days after hypoxic exposure (17). 
In this study, the Griess method was used to survey the role of noscapine on NO 
production induced by short-term oxygen–glucose deprivation /reperfusion. This study 
showed that 30 minutes ischemia/reperfusion could significantly increase NO production 
compared with external control. Besides, our findings revealed that noscapine could 
significantly reduce the NO production during 30 minutes of oxygen-glucose deprivation/
reperfusion indicating that attenuation of NO production may be one of the features of 
protective effect by noscapine during excitotoxicity. Furthermore, L-NAME, the NOS 
inhibitor, and MK-801, the non-competitive NMDA receptor antagonist, significantly 
decreased NO production during same assessments. The reduction of NO production by 
L-NAME and MK-801 were stronger comparing with noscapine. Although noscapine 
significantly decreased NO production, it could not attenuate the NO level to the level of the 
external control. Nevertheless, both L-NAME and MK-801 attenuated NO production to the 
level of external control, and there was not a significant difference between L-NAME and 
MK-801 in this effect. It seems that NO production in oligodendrocytes may be similar to 
neurons, in which NMDA receptor is linked to nNOS, and activation of nNOS leads to the 
production of NO and reactive oxygen species, which leads to cell death (51). Previous 
studies have also indicated that NOS inhibitors could noticeably reduce NO production after 
NMDA receptor activation, and decrease excitotoxic injury in cultured neurons (24, 39, 52). 
Other studies on toll-like receptors (TLRs) suggested related findings. TLRs receptors, 
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expressed mainly in sentinel cells of the immune system (50), also have important functions 
in oligodendrocytes (3, 49). Yao et al. through the in vitro and in vivo investigations on TLR 
mediated injury of demyelination by lipopolysaccharide, showed the involvement of 
increased NO production, and more importantly, a susceptibility of the oligodendrocytes to 
NO-mediated cell death by the activation of nNOS but not of iNOS (59, 60). 
Considering the potent protective effects of noscapine compared with NMDA and 
AMPA/kainate antagonists, and its potent effect in attenuation of intracellular Ca2+ levels in 
contrast to the weaker action on prevention of NO production, it is suggested that the 
protective effect of noscapine may be due to its inhibitory effect on intracellular Ca2+ overload.
In conclusion, noscapine, a non-toxic alkaloid from opium, protected the OLN-93 
oligodendrocytes during time-scheduled ischemia-induced damage. Additionally, noscapine 
significantly attenuated the intracellular Ca2+ elevation during chemical oxygen-glucose 
deprivation, and significantly decreased the production of NO during 30 minutes of oxygen-
glucose deprivation/reperfusion. These observations support the hypothesis that Ca2+ current 
and NO production during ischemic insult, have a role in causing cell damage. The potent 
inhibitory effect on intracellular Ca2+ overload by noscapine, compared with its weaker 
inhibition on NO production, seems to be the key mechanism for inhibition of ischemia-
induced excitotoxicity in oligodendrocytes although the detailed mechanism should be 
investigated. Thus, noscapine in nontoxic concentrations may be considered as an effective 
agent to reduce ischemia-induced excitotoxic injury in oligodendroglial cells.
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